![Nadia Waheed](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nadia Waheed
Technik-/Wissenschafts-/F&E-Leiter bei
OCULAR THERAPEUTIX, INC.
Vermögen: 3 Mio $ am 30.06.2026
Profil
Nadia K.
Waheed is currently Director at Iolyx Pharmaceuticals, Inc., Director at Bionic Sight LLC, Director at Boston Image Reading Center LLC since 2015, Chief Medical Officer at Ocular Therapeutix, Inc. since 2024, and Professor of Ophthalmology at Tufts University School of Medicine.
Former roles include Chief Medical Officer at Beacon Therapeutics (USA), Inc. and Chief Medical Officer & Head of Clinical Development at Gyroscope Therapeutics Holdings Plc.
Education includes graduate studies at Harvard T.H.
Chan School of Public Health and a doctorate from Aga Khan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.06.2026 | 300’079 ( 0.14% ) | 3 Mio $ | 30.06.2026 |
Aktive Positionen von Nadia Waheed
| Unternehmen | Position | Beginn |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 20.05.2024 |
Boston Image Reading Center LLC | Direktor/Vorstandsmitglied | 01.01.2015 |
Bionic Sight LLC
 Bionic Sight LLC Pharmaceuticals: MajorHealth Technology Develops optogenetic gene therapy vectors and devices to treat retinal degenerative diseases | Direktor/Vorstandsmitglied | - |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Nadia Waheed
| Unternehmen | Position | Ende |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | - |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Nadia Waheed
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aga Khan University
 Aga Khan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bionic Sight LLC
Bionic Sight LLC Pharmaceuticals: MajorHealth Technology Develops optogenetic gene therapy vectors and devices to treat retinal degenerative diseases | Health Technology |
Boston Image Reading Center LLC | Technology Services |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
